This keystone event will focus on the early stages of cancer drug research, with interactive debate and detailed presentations on a wide range of topics. A diverse line-up of academic and industry experts will be there to ensure fair and balanced coverage of the latest developments in the field. All this takes place in a friendly environment designed to encourage networking between attendees.

Conference Agenda

Hear in-depth presentations on a range of key issues of interest to those working in early stage oncology research and development. Topics include:

• Improving the Efficiency and Effectiveness of Cancer Drug Discovery
• Building and Maintaining Industry-Academia Alliances in Oncology
• Acquired Resistance to Targeted Kinase Inhibitors – Causes, Consequences & Solutions
• Discovery of a Novel Inhibitor of mTOR Pathway in Clinical Development
• Novel RNA Oligonucleotide that Inhibits Liver Carcinogenesis In Vivo
• Using Preclinical Data to Inform Clinical Dose & Schedule in Cancer Drug Trials
• Using Multi-Scale Modelling to Support Preclinical Developments
• Preclinical Models for Drug Discovery & Translating Combination Approaches to Clinical Trials